Verastem, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-09-04 EDT			5-day change	1st Jan Change
8.200 ^USD	+2.76%		+13.57%	+6.22%

08-11	Mizuho Adjusts Price Target on Verastem to $13 From $14, Keeps Outperform Rating	MT
08-07	Verastem, Inc. Amends Note Purchase Agreement to Establish New Series of Senior Secured Revenue Notes Up to $75 Million	CI

Published on 06/23/2026 at 05:45 pm EDT - Modified on 06/23/2026 at 09:07 pm EDT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good afternoon, and welcome to Verastem Oncology's VS-7375 R&D Update Conference Call. My name is Towanda, and I will be your call operator today.

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

08-11	Mizuho Adjusts Price Target on Verastem to $13 From $14, Keeps Outperform Rating	MT
08-07	Verastem, Inc. Amends Note Purchase Agreement to Establish New Series of Senior Secured Revenue Notes Up to $75 Million	CI
08-06	Verastem, Inc., Q2 2026 Earnings Call, Aug 06, 2026
08-06	Verastem, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-28	Verastem Oncology Doses First Patient in TARGET-D 203 Phase 2 Registration-Directed Trial of VS-7375 Oral KRAS G12D (ON/OFF) Inhibitor for KRAS G12D-Mutated Metastatic Colorectal Cancer	CI
07-22	Verastem Oncology Doses First Patient in Target-D 202 Phase 2 Registration-Directed Trial of Vs-7375 for Kras G12d-Mutated Advanced Non-Small Cell Lung Cancer	CI
07-07	RBC Capital Adjusts Verastem Price Target to $14 From $15, Maintains Outperform Rating	MT
06-29	Verastem, Inc.(NasdaqCM:VSTM) dropped from Russell Small Cap Comp Value Benchmark	CI
06-29	Verastem, Inc.(NasdaqCM:VSTM) dropped from Russell 3000 Value Benchmark	CI
06-28	Verastem, Inc.(NasdaqCM:VSTM) dropped from Russell 3000E Value Benchmark	CI
06-28	Verastem, Inc.(NasdaqCM:VSTM) dropped from Russell Microcap Value Benchmark Index	CI
06-28	Verastem, Inc.(NasdaqCM:VSTM) dropped from Russell 2500 Value Benchmark	CI
06-28	Verastem, Inc.(NasdaqCM:VSTM) dropped from Russell 2000 Value Benchmark	CI
06-24	Verastem's VS-7375 Update Reiterates Potential in US Patients, RBC Says	MT
06-23	Verastem, Inc. - Special Call

Duration

Period

Sector